Iron alters Ca2+ homeostasis in doxorubicin-resistant K562 cells

被引:2
作者
Yalcintepe, Leman [1 ]
Erdag, Demet [1 ]
Akbas, Fahri [2 ]
Kucukkaya, Bahire [3 ]
机构
[1] Istanbul Univ, Istanbul Fac Med, Dept Biophys, Istanbul, Turkey
[2] Bezmialem Vakif Univ, Fac Med, Dept Med Biol, Istanbul, Turkey
[3] Istanbul Yeni Yuzyil Univ, Fac Med, Dept Biophys, Istanbul, Turkey
关键词
doxorubicin; drug resistance; intracellular calcium; iron; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; MULTIDRUG-RESISTANCE; INTRACELLULAR CALCIUM; MOLECULAR-MECHANISMS; NA+/CA2+ EXCHANGERS; THERAPY RESISTANCE; P-GLYCOPROTEIN; CANCER; SENSITIVITY; METABOLISM;
D O I
10.1111/1440-1681.13295
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Iron is an essential trace element especially in cell proliferation, and growth for various cellular events. An increasing amount of research has shown that iron metabolism is altered in tumour cells which usually have rapid growth rates. However, the number of studies on iron metabolism, and calcium regulation are limited in drug-resistant tumour cells. Previously, we have shown that modulation of iron metabolism through iron chelation regulated the intracellular calcium, and increased the doxorubicin sensitivity. In the present study, we investigated the effects of iron on mRNA expression profiles of fifteen key genes (IP(3)R1/2/3, RYR1/2, SERCA1/2/3, NCX1/2/3, PMCA1/2/3, and PMCA4) related to calcium homeostasis in the parental cell line K562 and its subclone doxorubicin-resistant K562 cells. According to the Delta Delta Ct method with a two-fold expression difference (P < .05) as a cut-off level, although iron showed differential effects on most of the genes, IP3R and PMCA genes were especially determined to have changed significantly. These results show that iron metabolism is an important metabolism due to changes in the expression of genes involved in calcium regulation and is a new perspective to overcome cancer/drug resistance.
引用
收藏
页码:1221 / 1230
页数:10
相关论文
共 45 条
  • [1] Cisplatin (CDDP) triggers cell death of MCF-7 cells following disruption of intracellular calcium ([Ca2+]i) homeostasis
    Al-Taweel, Nawaf
    Varghese, Elizabeth
    Florea, Ana-Maria
    Buesselberg, Dietrich
    [J]. JOURNAL OF TOXICOLOGICAL SCIENCES, 2014, 39 (05) : 765 - 774
  • [2] Caspase-3-induced truncation of type 1 inositol trisphosphate receptor accelerates apoptotic cell death and induces inositol trisphosphate-independent calcium release during apoptosis
    Assefa, Z
    Bultynck, G
    Szlufcik, K
    Kasri, NN
    Vermassen, E
    Goris, J
    Missiaen, L
    Callewaert, G
    Parys, JB
    De Smedt, H
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (41) : 43227 - 43236
  • [3] The versatility and universality of calcium signalling
    Berridge, MJ
    Lipp, P
    Bootman, MD
    [J]. NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2000, 1 (01) : 11 - 21
  • [4] The role of iron chelation in cancer therapy
    Buss, JL
    Torti, FM
    Torti, SV
    [J]. CURRENT MEDICINAL CHEMISTRY, 2003, 10 (12) : 1021 - 1034
  • [5] CAZZOLA M, 1990, BLOOD, V75, P1903
  • [6] Du Y, 2017, ONCOTARGET, V8, P68270, DOI 10.18632/oncotarget.19295
  • [7] Inositol trisphosphate receptor Ca2+ release channels
    Foskett, J. Kevin
    White, Carl
    Cheung, King-Ho
    Mak, Don-On Daniel
    [J]. PHYSIOLOGICAL REVIEWS, 2007, 87 (02) : 593 - 658
  • [8] Multidrug resistance in cancer: Role of ATP-dependent transporters
    Gottesman, MM
    Fojo, T
    Bates, SE
    [J]. NATURE REVIEWS CANCER, 2002, 2 (01) : 48 - 58
  • [9] GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440
  • [10] Genetic landscape of metastatic and recurrent head and neck squamous cell carcinoma
    Hedberg, Matthew L.
    Goh, Gerald
    Chiosea, Simion I.
    Bauman, Julie E.
    Freilino, Maria L.
    Zeng, Yan
    Wang, Lin
    Diergaarde, Brenda B.
    Gooding, William E.
    Lui, Vivian W. Y.
    Herbst, Roy S.
    Lifton, Richard P.
    Grandis, Jennifer R.
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2016, 126 (01) : 169 - 180